GNI Group Ltd.

GNI Group Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY18.51
Market Cap
JPY53.45 B
Shares Outstanding
13.9 M
Public Float
13.01 M

Profile

Address
Nihonbashi Honcho YS Bldg., 3/F
Tokyo Tokyo 103
Japan
Employees -
Website http://www.gnipharma.com
Updated 07/08/2019
GNI Group Ltd. engages in the development, research, manufacture, and sales of pharmaceutical drugs and traditional Chinese medicines. It operates through Japan and China segments. The Japan segment deals with licensing, preclinical studies, clinical trials, and sales.

Financials

View All

Ying Luo
President, Chief Executive Officer & Director
Thomas Eastling
Chief Financial Officer & Director